MASSIVE DUMP $QURE FOR A TRADE HERE uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington's

MASSIVE DUMP $QURE FOR A TRADE HERE uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington's Disease Showing Continued Slowing of Disease Progression 29 minutes ago The Company’s analysis of the updated control showed that patients …